West Financial Statements From 2010 to 2024

Stocks . USA . 
Stock . West Pharmaceutical Services
WST Stock  USD 378.81  1.19  0.31%   
West Pharmaceutical financial statements provide useful quarterly and yearly information to potential West Pharmaceutical Services investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on West Pharmaceutical financial statements helps investors assess West Pharmaceutical's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting West Pharmaceutical's valuation are summarized below:
Gross Profit
1.1 B
Profit Margin
0.2012
Market Capitalization
27.8 B
Enterprise Value Revenue
9.2458
Revenue
2.9 B
There are currently one hundred twenty fundamental gauges for West Pharmaceutical that can be evaluated and compared over time across peers. All traders should confirm West Pharmaceutical's prevalent fundamentals against the performance from 2010 to 2024 and make sure the trends continue to evolve in the right direction. Market Cap is likely to drop to about 216.9 M in 2024. Enterprise Value is likely to drop to about 252.4 M in 2024

West Pharmaceutical Total Revenue

3.1 Billion

Check West Pharmaceutical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among West main balance sheet or income statement drivers, such as Depreciation And Amortization of 144.2 M, Total Revenue of 3.1 B or Gross Profit of 1.2 B, as well as many exotic indicators such as Price To Sales Ratio of 9.31, Dividend Yield of 0.0021 or PTB Ratio of 9.54. West financial statements analysis is a perfect complement when working with West Pharmaceutical Valuation or Volatility modules.
  
This module can also supplement West Pharmaceutical's financial leverage analysis and stock options assessment as well as various West Pharmaceutical Technical models . Check out the analysis of West Pharmaceutical Correlation against competitors.

West Pharmaceutical Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Total Assets4 B3.8 B2.2 B
Slightly volatile
Short and Long Term Debt Total227.6 M309 M283.7 M
Very volatile
Other Current Liabilities247.8 M236 M152.4 M
Slightly volatile
Total Current Liabilities705.4 M671.8 M364.3 M
Slightly volatile
Total Stockholder Equity3 B2.9 B1.5 B
Slightly volatile
Property Plant And Equipment Net1.6 B1.5 B891 M
Slightly volatile
Retained Earnings3.7 B3.5 B1.6 B
Slightly volatile
Cash896.6 M853.9 M417.4 M
Slightly volatile
Non Current Assets Total2 B1.9 B1.2 B
Slightly volatile
Non Currrent Assets Other33.8 M21.3 M29.1 M
Slightly volatile
Cash And Short Term Investments896.6 M853.9 M418.7 M
Slightly volatile
Net Receivables537.6 M512 M292.3 M
Slightly volatile
Common Stock Shares Outstanding74.7 M75.3 M73.8 M
Slightly volatile
Liabilities And Stockholders Equity4 B3.8 B2.1 B
Slightly volatile
Non Current Liabilities Total307.8 M276.7 M377.9 M
Very volatile
Inventory456.4 M434.7 M249.8 M
Slightly volatile
Other Current Assets142.6 M135.8 M64.1 M
Slightly volatile
Total Liabilities995.9 M948.5 M614.9 M
Slightly volatile
Total Current Assets2 B1.9 B1 B
Slightly volatile
Short Term Debt159.3 M151.7 M46.5 M
Slightly volatile
Intangible Assets14.3 M15.1 M29.1 M
Slightly volatile
Accounts Payable254.5 M242.4 M149.7 M
Slightly volatile
Property Plant And Equipment Gross3 B2.8 B1.2 B
Slightly volatile
Common Stock Total Equity13 M21.6 M16.1 M
Slightly volatile
Common Stock13.3 M21.6 M16.1 M
Slightly volatile
Other Liabilities107.9 M130.2 M120.7 M
Pretty Stable
Long Term Debt69.2 M72.8 M231.2 M
Slightly volatile
Good Will103.1 M108.5 M104.5 M
Slightly volatile
Property Plant Equipment1.4 B1.3 B854.7 M
Slightly volatile
Current Deferred Revenue38.2 M41.7 M40.3 M
Very volatile
Net Tangible Assets3.1 B2.9 B1.4 B
Slightly volatile
Long Term Debt Total209.4 M186 M258.9 M
Slightly volatile
Capital Surpluse223.1 M267 M208.8 M
Slightly volatile
Long Term Investments133.7 M210 M118.3 M
Slightly volatile
Non Current Liabilities Other102.4 M58.5 M128.5 M
Slightly volatile
Deferred Long Term Asset Charges12 M12.6 M43 M
Slightly volatile
Short and Long Term Debt140.7 M134 M35.9 M
Slightly volatile
Cash And Equivalents548.1 M1 B418.8 M
Slightly volatile
Net Invested Capital2.4 B3.1 B1.9 B
Slightly volatile
Net Working Capital1 B1.3 B716 M
Slightly volatile
Capital Stock15 M16.9 M18.4 M
Slightly volatile
Capital Lease Obligations93.7 M102.2 M77.8 M
Slightly volatile

West Pharmaceutical Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization144.2 M137.3 M97.6 M
Slightly volatile
Total Revenue3.1 B2.9 B1.8 B
Slightly volatile
Gross Profit1.2 B1.1 B645.8 M
Slightly volatile
Other Operating Expenses2.4 B2.2 B1.5 B
Slightly volatile
Operating Income709.8 M676 M332.2 M
Slightly volatile
EBIT775.3 M738.4 M325.3 M
Slightly volatile
EBITDA919.5 M875.7 M422.9 M
Slightly volatile
Cost Of Revenue1.9 B1.8 B1.2 B
Slightly volatile
Total Operating Expenses442.9 M421.8 M302.8 M
Slightly volatile
Income Before Tax732.9 M698 M324.3 M
Slightly volatile
Net Income623.1 M593.4 M270.6 M
Slightly volatile
Income Tax Expense128.4 M122.3 M64.1 M
Slightly volatile
Selling General Administrative194.7 M353.4 M250 M
Slightly volatile
Research Development71.8 M68.4 M43 M
Slightly volatile
Net Income Applicable To Common Shares707.5 M673.8 M277.4 M
Slightly volatile
Net Income From Continuing Ops623.1 M593.4 M266.5 M
Slightly volatile
Tax Provision83 M122.3 M59.5 M
Slightly volatile
Interest Income29.4 M28 M10.5 M
Pretty Stable
Reconciled Depreciation124.7 M137.3 M106.4 M
Slightly volatile

West Pharmaceutical Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Stock Based Compensation12.2 M23.3 M20 M
Slightly volatile
Free Cash Flow435.2 M414.5 M189.2 M
Slightly volatile
Begin Period Cash Flow939 M894.3 M370.4 M
Slightly volatile
Depreciation144.2 M137.3 M97.8 M
Slightly volatile
Dividends Paid59.9 M57 M38.2 M
Slightly volatile
Capital Expenditures380.1 M362 M176.6 M
Slightly volatile
Total Cash From Operating Activities815.3 M776.5 M365.8 M
Slightly volatile
Net Income623.1 M593.4 M271 M
Slightly volatile
End Period Cash Flow896.6 M853.9 M416.9 M
Slightly volatile

Financial Ratios

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio9.318.86935.1419
Slightly volatile
Dividend Yield0.00210.00220.0069
Slightly volatile
PTB Ratio9.549.08116.2037
Slightly volatile
Days Sales Outstanding42.7363.353454.1795
Slightly volatile
Book Value Per Share40.7138.775220.5229
Slightly volatile
Free Cash Flow Yield0.02510.01580.0202
Slightly volatile
Invested Capital0.10.10730.2558
Slightly volatile
Operating Cash Flow Per Share10.9710.45094.9917
Slightly volatile
Stock Based Compensation To Revenue0.00560.00790.0112
Very volatile
PB Ratio9.549.08116.2037
Slightly volatile
EV To Sales9.128.68455.1216
Slightly volatile
Free Cash Flow Per Share5.865.57872.5687
Slightly volatile
ROIC0.180.16940.1264
Slightly volatile
Inventory Turnover6.44.18825.1081
Slightly volatile
Net Income Per Share8.397.98653.6783
Slightly volatile
Days Of Inventory On Hand51.8987.150172.1003
Slightly volatile
Payables Turnover11.817.51078.7152
Slightly volatile
Sales General And Administrative To Revenue0.180.15310.1634
Pretty Stable
Research And Ddevelopement To Revenue0.01790.02320.0227
Slightly volatile
Cash Per Share12.0711.49265.7006
Slightly volatile
POCF Ratio35.3833.692926.1419
Slightly volatile
Interest Coverage78.8775.111141.9981
Slightly volatile
Payout Ratio0.09130.09610.2039
Slightly volatile
PFCF Ratio66.2763.118358.5749
Slightly volatile
Days Payables Outstanding28.6648.597242.9632
Slightly volatile
Income Quality1.241.30861.598
Slightly volatile
ROE0.220.2060.1576
Slightly volatile
EV To Operating Cash Flow34.6432.991126.2357
Slightly volatile
PE Ratio23.1844.089236.1438
Slightly volatile
Return On Tangible Assets0.170.16010.1124
Slightly volatile
EV To Free Cash Flow64.8961.803759.5773
Pretty Stable
Earnings Yield0.02150.02270.0314
Slightly volatile
Intangibles To Total Assets0.03070.03230.0667
Slightly volatile
Current Ratio1.832.88242.7123
Pretty Stable
Tangible Book Value Per Share38.9737.111720.1019
Slightly volatile
Receivables Turnover7.685.76136.8386
Slightly volatile
Graham Number87.6583.473440.7569
Slightly volatile
Shareholders Equity Per Share40.7138.775220.5229
Slightly volatile
Debt To Equity0.10.10730.2558
Slightly volatile
Revenue Per Share41.6939.701225.0739
Slightly volatile
Interest Debt Per Share2.544.27994.1208
Very volatile
Debt To Assets0.07670.08070.1534
Slightly volatile
Enterprise Value Over EBITDA30.7229.253925.9843
Slightly volatile
Short Term Coverage Ratios4.865.118725.3324
Very volatile
Price Earnings Ratio23.1844.089236.1438
Slightly volatile
Operating Cycle94.62151126
Slightly volatile
Price Book Value Ratio9.549.08116.2037
Slightly volatile
Days Of Payables Outstanding28.6648.597242.9632
Slightly volatile
Dividend Payout Ratio0.09130.09610.2039
Slightly volatile
Price To Operating Cash Flows Ratio35.3833.692926.1419
Slightly volatile
Price To Free Cash Flows Ratio66.2763.118358.5749
Slightly volatile
Pretax Profit Margin0.250.23660.1562
Slightly volatile
Ebt Per Ebit0.981.03250.954
Slightly volatile
Operating Profit Margin0.240.22920.1609
Slightly volatile
Effective Tax Rate0.290.17520.2484
Slightly volatile
Company Equity Multiplier2.121.32921.6245
Slightly volatile
Long Term Debt To Capitalization0.04920.05180.173
Slightly volatile
Total Debt To Capitalization0.0920.09690.1941
Slightly volatile
Return On Capital Employed0.220.21410.1609
Slightly volatile
Debt Equity Ratio0.10.10730.2558
Slightly volatile
Ebit Per Revenue0.240.22920.1609
Slightly volatile
Quick Ratio1.132.03321.8022
Slightly volatile
Net Income Per E B T0.580.85010.7765
Pretty Stable
Cash Ratio1.331.27111.0243
Slightly volatile
Cash Conversion Cycle94.7310287.1535
Slightly volatile
Operating Cash Flow Sales Ratio0.280.26320.1824
Slightly volatile
Days Of Inventory Outstanding51.8987.150172.1003
Slightly volatile
Days Of Sales Outstanding42.7363.353454.1795
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio0.560.53380.449
Slightly volatile
Cash Flow Coverage Ratios2.642.51291.2344
Slightly volatile
Price To Book Ratio9.549.08116.2037
Slightly volatile
Fixed Asset Turnover1.581.95032.0069
Pretty Stable
Price Cash Flow Ratio35.3833.692926.1419
Slightly volatile
Enterprise Value Multiple30.7229.253925.9843
Slightly volatile
Debt Ratio0.07670.08070.1534
Slightly volatile
Cash Flow To Debt Ratio2.642.51291.2344
Slightly volatile
Price Sales Ratio9.318.86935.1419
Slightly volatile
Return On Assets0.160.1550.1058
Slightly volatile
Asset Turnover0.980.77030.8661
Pretty Stable
Net Profit Margin0.210.20120.1264
Slightly volatile
Gross Profit Margin0.260.38280.3323
Slightly volatile
Price Fair Value9.549.08116.2037
Slightly volatile
Return On Equity0.220.2060.1576
Slightly volatile

West Pharmaceutical Valuation Data

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Market Cap216.9 M350.4 M362.9 M
Very volatile
Enterprise Value252.4 M374.8 M390 M
Very volatile

West Fundamental Market Drivers

Forward Price Earnings49.7512
Cash And Short Term Investments853.9 M

West Upcoming Events

15th of February 2024
Upcoming Quarterly Report
View
25th of April 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
15th of February 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About West Pharmaceutical Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include West Pharmaceutical income statement, its balance sheet, and the statement of cash flows. West Pharmaceutical investors use historical funamental indicators, such as West Pharmaceutical's revenue or net income, to determine how well the company is positioned to perform in the future. Although West Pharmaceutical investors may use each financial statement separately, they are all related. The changes in West Pharmaceutical's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on West Pharmaceutical's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on West Pharmaceutical Financial Statements. Understanding these patterns can help to make the right decision on long term investment in West Pharmaceutical. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Current Deferred Revenue41.7 M38.2 M
Total Revenue2.9 B3.1 B
Cost Of Revenue1.8 B1.9 B
Stock Based Compensation To Revenue 0.01  0.01 
Sales General And Administrative To Revenue 0.15  0.18 
Research And Ddevelopement To Revenue 0.02  0.02 
Capex To Revenue(0.12)(0.13)
Revenue Per Share 39.70  41.69 
Ebit Per Revenue 0.23  0.24 

West Pharmaceutical Investors Sentiment

The influence of West Pharmaceutical's investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in West. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock market does not have solid backing from leading economists and market statisticians.
Investor biases related to West Pharmaceutical's public news can be used to forecast risks associated with an investment in West. The trend in average sentiment can be used to explain how an investor holding West can time the market purely based on public headlines and social activities around West Pharmaceutical Services. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
West Pharmaceutical's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for West Pharmaceutical's and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average West Pharmaceutical's news discussions. The higher the estimated score, the more favorable is the investor's outlook on West Pharmaceutical.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards West Pharmaceutical in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, West Pharmaceutical's short interest history, or implied volatility extrapolated from West Pharmaceutical options trading.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
LTCLitecoin
STETHStaked Ether
LINKChainlink
When determining whether West Pharmaceutical is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if West Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about West Pharmaceutical Services Stock. Highlighted below are key reports to facilitate an investment decision about West Pharmaceutical Services Stock:
How To Invest In West
Details
Is West Stock a good investment?
Details
What is West Pharmaceutical's Net Worth?
Details
Largest Health Care Equipment & Supplies Companies
View
Largest Health Care Equipment & Services Companies
View
Check out the analysis of West Pharmaceutical Correlation against competitors.
You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.

Complementary Tools for West Stock analysis

When running West Pharmaceutical's price analysis, check to measure West Pharmaceutical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy West Pharmaceutical is operating at the current time. Most of West Pharmaceutical's value examination focuses on studying past and present price action to predict the probability of West Pharmaceutical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move West Pharmaceutical's price. Additionally, you may evaluate how the addition of West Pharmaceutical to your portfolios can decrease your overall portfolio volatility.
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
CEOs Directory
Screen CEOs from public companies around the world
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Is West Pharmaceutical's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of West Pharmaceutical. If investors know West will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about West Pharmaceutical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.334
Dividend Share
0.77
Earnings Share
7.87
Revenue Per Share
39.701
Quarterly Revenue Growth
0.033
The market value of West Pharmaceutical is measured differently than its book value, which is the value of West that is recorded on the company's balance sheet. Investors also form their own opinion of West Pharmaceutical's value that differs from its market value or its book value, called intrinsic value, which is West Pharmaceutical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because West Pharmaceutical's market value can be influenced by many factors that don't directly affect West Pharmaceutical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Altman
Z Score
Details
Piotroski
F Score
Details
Beneish
M Score
Details
Financial
Analysis
Details
Buy or Sell
Advice
Details
Earnings
Projections
Details
Please note, there is a significant difference between West Pharmaceutical's value and its price as these two are different measures arrived at by different means. Investors typically determine if West Pharmaceutical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, West Pharmaceutical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY